z-logo
open-access-imgOpen Access
Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
Author(s) -
David Casadevall,
Xiaotong Li,
Ryan L. Powles,
Vikram B. Wali,
Natália Buza,
Vasiliki Pelekanou,
Arjun Dhawan,
Julia Foldi,
Borbála Székely,
Francesc López-Giráldez,
Christos Hatzis,
Lajos Pusztai
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00335
Subject(s) - breast cancer , chemotherapy , blockade , triple negative breast cancer , medicine , oncology , neoadjuvant therapy , immune system , triple negative , cancer research , cancer , immunology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here